Julia Stalder: What DCIS and Hereditary Cancer Risk Share, From Uncertainty to Self-Advocacy
Episode Summary
Julia Stalder went in for a routine screening mammogram in February 2024 and came out on a path toward a diagnosis she had never heard of: ductal carcinoma in situ, or DCIS, sometimes called stage 0 breast cancer. Her genetic testing showed no predisposition, and she had little family history. What she found as she tried to understand her diagnosis was a gap. There were very few resources specific to DCIS, and the research couldn't yet say which cases would progress to invasive cancer and which might stay in the milk ducts for a lifetime. Julia sought three surgical opinions. Rather than the mastectomy she was recommended, she chose active surveillance, a newer approach being studied in clinical trials, with close monitoring and the freedom to change course at any time. That process of learning, asking questions, and choosing became the foundation for DCIS Understood, the nonprofit she founded to bring evidence-based education and research funding to people facing this diagnosis.
This episode steps slightly outside hereditary cancer, but as Sara says, DCIS shares nearly every emotional and relational layer of the genetic risk experience. Both diagnoses hand people information about something that may or may not happen, then ask them to decide what to do with it. Sara and Julia explore how trauma history, the provider in the room, and access to time and insurance shape how that information lands. Sara names a hard truth for both communities: surgery is often chosen in hopes of finding peace, but there is no perfect solution, and recurrence anxiety and grief can remain either way. Julia offers a generous view of providers, who also have to sit with uncertainty, and a reminder that some patients simply want to be told what to do. Throughout, both return to the same place: decisions come from an emotional place, and that deserves respect, support, and integration.
We Cover
Julia's DCIS diagnosis after a routine screening mammogram, and why it felt like it came out of nowhere
What DCIS is, as Julia describes it as a patient: abnormal cells in the milk ducts that have not spread into surrounding breast tissue
The lack of education and resources specific to DCIS, and how that gap led Julia to advocacy
Why the language of “stage zero,” “pre-cancer,” and “risk factor” creates confusion and fear
The emotional overlap between DCIS and carrying a hereditary cancer mutation
How trauma history, family stress, and past medical experiences shape how a diagnosis lands
Access to multiple opinions, and how insurance and location can limit patients' options
A provider's nervous system and how their way of holding uncertainty affects the patient
Julia's choice of active surveillance, with alternating mammograms and MRIs and low-dose hormone therapy
Why active surveillance isn't presented to most patients, and the importance of knowing your pathology
Julia's understanding of how widespread mammography changed the number of DCIS diagnoses
Questions about overtreatment, the side effects of surgery, radiation, and hormone therapy, and parallels with active surveillance in prostate cancer
Surgery as an attempt to find safety, and why recurrence anxiety often remains
Holding complexity and building a loving relationship with the frightened parts of ourselves
Grief after preventive mastectomy, remorse after waiting, and why neither has to mean the decision was wrong
Compassion for providers who also sit with uncertainty, and respect for patients who want a clear recommendation
How being a mother to her daughter motivates Julia to push DCIS research forward
How far breast cancer treatment has come, and how much further it can go
Highlights & takeaways
“It has given me so much agency around the diagnosis. And I think that has reduced my own trauma.” For Julia, learning, seeking opinions, and building something from her experience changed how her diagnosis lived in her.
“What ultimately made me feel like my provider was the right one for me was that he acknowledged the uncertainty.” A provider willing to say “we don't know yet” can make room for a patient's own decision.
Many people move quickly into surgery hoping it will bring peace and put the experience behind them. Sara offers a harder truth: there is no perfect solution, and the work is building the capacity to hold complexity with compassion.
“It wasn't the wrong decision, but we're making space for the sadness.” Grief after a preventive surgery, or remorse after waiting, doesn't mean someone chose wrong.
“Decision making comes from an emotional place. That's not a bad thing.” Sara names why mental health care belongs inside medical decision-making, not alongside it.
Not every patient wants to grapple with uncertainty. Julia reminds listeners that some people simply want a clear recommendation, and that is valid too.
Content Note
This episode includes discussion of a breast cancer diagnosis, biopsies and imaging, treatment decisions including mastectomy, radiation, and hormone therapy, recurrence anxiety, medical trauma, references to histories of abuse, historical radical mastectomies, preventive mastectomy and grief about breastfeeding, and remorse following a cancer diagnosis.
Resources Mentioned
DCIS Understood: A nonprofit working to increase education and awareness about DCIS and accelerate research through education, advocacy, and funding. Its educational content is vetted by an advisory board of breast cancer physicians and researchers. dcisunderstood.org
DCIS Understood on Social Media:
Connect
If this conversation spoke to you, follow Walking the Genetic Line, rate and review the show, and share this episode with someone who has been handed a diagnosis that came with more questions than answers.
Connect with Sara Champie, LCSW at sarachampielcsw.com and on Instagram @SaraChampieLCSW.
Let’s walk this line, together.
Additional support
Therapy with Sara Champie, LCSW: Psychotherapy for people navigating breast cancer diagnoses, hereditary cancer risk, treatment decisions, and medical uncertainty. sarachampielcsw.com
Walking the Genetic Line Therapy and Support Group: A group space with Sara for people navigating hereditary cancer risk. sarachampielcsw.com/support-groups
DCIS Understood: Evidence-based education for people newly diagnosed with DCIS and their families. dcisunderstood.org
Sara Champie